Ketamine for cocaine-related disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Nov 2023: Trial registered, NCT06125054
  2. 5 Feb 2024: Trial started, NCT06125054

The trials

NCT06125054: Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction

State
Under way
Phase
Phase 2
People
120 planned
Started
5 Feb 2024
Primary completion
Dec 2025
Arms
sham NFT / Ketamine
Results
None posted
  1. 9 Nov 2023: Trial registered
  2. 5 Feb 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as 0.2 mg/kg ketamine, 1st perfusion of ketamine, 2nd perfusion of ketamine, Anaket v, Calypsol, CLORKETAM 1000, IMALGENE 1000, Intranasal Ketamine (IN), Intranasal ketamine, Ketafol component ketamine, KETASOL 100, Ketamine Infusion, Narketan, Tekam, Ursotamin, Vetaket.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.